14.01.2010: BIND Biosciences announces the closing of a $11M Series C financing to advance BIND's preclinical product pipeline and to expand its product development capabilities. The investment was led by DHK Investment, representing, David H. Koch, with participation by all existing investors, Polaris Venture Partners, Flagship Ventures, ARCH Venture Partners and NanoDimension.

Press Release